ICDcodes.org
FY2027

R87.614 — Cytologic evidence of malignancy on smear of cervix

Billable

Is R87.614 billable?

Yes — R87.614 is billable for FY2027. R87.614 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. R87.614 may be submitted for encounters from October 1, 2026 through September 30, 2027.

R87.614 at a glance

CodeR87.614
DescriptionCytologic evidence of malignancy on smear of cervix
BillableYes
Code setICD-10-CM FY2027
Valid for encountersOctober 1, 2026 – September 30, 2027

Which MS-DRGs does R87.614 group to?

R87.614 sits in MDC 13 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.

  • 742Uterine and Adnexa Procedures for Non-Malignancy with CC/MCCsurgical
  • 743Uterine and Adnexa Procedures for Non-Malignancy without CC/MCCsurgical

How is R87.614 listed in the Alphabetic Index?

These are the routes through the Alphabetic Index that lead to R87.614. They show the wording a clinician may have documented, which often differs from the Tabular description.

  • Evidence › cytologic › of malignancy on cervical smear
  • Abnormal, abnormality, abnormalities › Papanicolaou › cervix › cytologic evidence of malignancy

Excludes1 — never code together — inherited from R83-R89

The conditions below can never be reported together with R87.614 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • abnormal findings on antenatal screening of mother (O28.-)
  • diagnostic abnormal findings classified elsewhere - see Alphabetical Index

Excludes1 — never code together — inherited from R87.61

The conditions below can never be reported together with R87.614 on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.

  • abnormal cytological findings in specimens from other female genital organs (R87.69)
  • abnormal cytological findings in specimens from vagina (R87.62-)
  • carcinoma in situ of cervix uteri (histologically confirmed) (D06.-)
  • cervical intraepithelial neoplasia I [CIN I] (N87.0)
  • cervical intraepithelial neoplasia II [CIN II] (N87.1)
  • cervical intraepithelial neoplasia III [CIN III] (D06.-)
  • dysplasia (mild) (moderate) of cervix uteri (histologically confirmed) (N87.-)
  • severe dysplasia of cervix uteri (histologically confirmed) (D06.-)

Excludes2 — not included here — inherited from Chapter 18

The conditions below are not part of R87.614, but a patient may have both at the same time. When documentation supports it, R87.614 and the excluded code may both be reported.

  • abnormal findings on antenatal screening of mother (O28.-)
  • certain conditions originating in the perinatal period (P04-P96)
  • signs and symptoms classified in the body system chapters
  • signs and symptoms of breast (N63, N64.5)

Excludes2 — not included here — inherited from R83-R89

The conditions below are not part of R87.614, but a patient may have both at the same time. When documentation supports it, R87.614 and the excluded code may both be reported.

  • abnormal findings on examination of blood, without diagnosis (R70-R79)
  • abnormal findings on examination of urine, without diagnosis (R80-R82)
  • abnormal tumor markers (R97.-)

Excludes2 — not included here — inherited from R87.61

The conditions below are not part of R87.614, but a patient may have both at the same time. When documentation supports it, R87.614 and the excluded code may both be reported.

  • cervical high risk human papillomavirus (HPV) DNA test positive (R87.810)
  • cervical low risk human papillomavirus (HPV) DNA test positive (R87.820)

How long has R87.614 existed?

R87.614 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.

Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.

What other codes are in the R87.61 family? (8)